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BioinformaticsGenes and miRNAs involved in sarcomagenesis related pathways are unknown and therefore signaling events
leading to mesenchymal cell transformation to sarcoma are poorly elucidated. Exiqon and Illumina microarray
study on human chondrosarcoma JJ012 and chondrocytes C28 cell lines to compare and analyze the differentially
expressed miRNAs and their gene targets was recently published in the Journal Tumor Biology in 2014. Here we
describe in details the contents and quality controls for themiRNA and gene expression data associatedwith the
study that is relevant to this dataset.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).SpeciﬁcationsOrganism/cell line/tissue Human Chondrosarcoma JJ012 and Chondrocytes C28
Cell linesSex Not applicable
Sequencer or array type Exiqon miRNA array and Illumina Human HT-12 Gene
expression array
Data format Raw
Experimental factors Tumor vs normal
Experimental features Whole genome coverage transcriptional coverage of
characterized and uncharacterized RNAs using arrays
Consent Not applicable
Sample source location Miami, Florida, USADirect link to deposited data
Deposited data can be found here: http://www.ncbi.nlm.nih.gov/
geo/query/acc.cgi?acc=GSE48420.component analysis.
1 305 243 9342.
. This is an open access article underExperimental design, materials and methods
Study cell line data
Human chondrosarcoma (JJ012) and chrondrocytes (C28) cell lines
were obtained from the University of Miami Tissue bank and cultured
in monolayer until they were semiconﬂuent as described previously
[1,2]. Cells were lysed and 100 μg of total RNA from the sample was pre-
pared using the Qiagen RNeasy mini kit. NanoDrop 8000 spectrometer
was used to check for RNA integrity and the presence of small RNA frac-
tions was determined using Agilent Bioanalyzer 2100.miRNA expression data
20 ng of total RNA per panel was reverse transcribed using the
miRCURY LNA™ Universal RT microRNA PCR and polyadenylation
and cDNA synthesis kit (Exiqon, Woburn, MA). For each sample,
the cDNA was diluted, and each reaction was combined with SYBR
Green Master Mix (Exiqon) and added to the Ready-to-Use PCR
panels. Human microRNA Ready-to-Use PCR panels I and II hold
743 different miRNA targets and six reference gene assays
(mirBase13). They were tested on a Roche LightCycler 480 real-
time PCR instrument.the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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Weused theGenEx version5 software fromMultiDAnalysesAB to an-
alyze the RT-PCR data of the human miRNAs. Layout ﬁles for human
panels I and II version 2 with miRBase 16 annotations was loaded on
the software. miRNA expression data was imported and sample and
group classiﬁcation columns were appropriately modiﬁed to deﬁne the
replicates. The groups were labeled as ‘SARC’ for human chondrosarcoma
and ‘C28’ for chondrocytes. The data was pre-processed as provided by
the software guidelines. Interplate calibration was performed using
mean values between plates. Outlier data points were deleted from anal-
ysis using Grubb's test on replicates with default conﬁdence level (0.95)
and cut-off SD (0.25). All values which were larger than 37 (default)
were replaced with a blank and all empty rows and undetected miRNAs
were removed. Missing ‘NaN’ values were also replaced and the data
was validated to remove data points for miRNAs which had less than
75% values from replicates within a group. All remaining missing values
were now imputed based on groups and empty cells were ﬁlled with a
value of 38 as recommended.
Normalization
As recommended by the software user guide for screening studies,
variability arising from differences in sample handling was minimized
using global mean normalization with mean expression of all genes.
Markers with Cq larger than 34 were not included as directed. Repli-
cates were averaged and values were converted to relative quantities
on the linear scale prior to log2 conversion.
Basic analysis
The processedmiRNA data was analyzed using hierarchical clustering
(Fig. 1) and principal component analysis (Fig. 2) methods to visuallyFig. 1. Hierarchical clustering of miRNA expression data from human choninterpret the differential expression between groups. The groups were
noted to have sufﬁcient differences for a more robust statistical signiﬁ-
cance analysis. The C28 and SARC were compared using a 2-tailed un-
paired T-test and the resulting P-values were corrected for false
discovery using the well documented Benjamini–Hochberg method
(Fig. 3).Gene expression data
Expression data was obtained by hybridizing extracted RNA from
samples to HumanHT-12 V4_0_R1 array platform from Illumina. Care
was taken to obtain RNA aliquots of same harvested cells as with
miRNA expression data.Quality control
The mRNA expression data were loaded on GeneSpring® 12.5 GX
(Agilent Technologies, Santa Clara, CA, USA). The data for all probes
including those with missing values were included in the pre-
processing steps. Quality assessments were done visually using var-
ious plots including PCA (Fig. 4). All samples were found to be of high
quality with intra-group correlation of expression data within 98–
99% match.Normalization
Normalization of themRNA expression data was performed using the
‘Quantile’ normalization method available in GeneSpring and the data
was log2 transformed to the mean of all samples before statistical
analyses.drosarcomas JJ012 (SARC) and human chondrocytes (C28) cell lines.
Fig. 2. Principal component analysis (PCA) plot on miRNA expression data from human chondrosarcoma (SARC) and chondrocytes (C28) using the ﬁrst two components.
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Since one objective of the study was to cross-compare signiﬁcant
miRNA expressionwithin groups to their target mRNA expression, statis-
tical signiﬁcance test was performed between human chondrosarcoma
(SARC) and chrondrocytes (C28) as with miRNA expression data.Fig. 3.miRNAs with statistical signiﬁcance after a T-test are shown in green on a volcano plot
signiﬁcance are shown in red and gray respectively.Multiple testing corrections on nominal P-values were performed using
Benjamini–Hochberg method (Fig. 5). Predicted and validated gene tar-
gets for miRNAs were obtained from miRWalk database (http://www.
umm.uni-heidelberg.de/apps/zmf/mirwalk/index.html). Gene expression
data for targets of signiﬁcant miRNAs werematched from the differential
mRNA expression obtained above.above. Those with marginal signiﬁcance are shown in yellow, while those with low or no
Fig. 4. Principal component analysis (PCA) plot using ﬁrst 3 components on mRNA expression data from human chondrosarcoma (SARC) in blue and human chondrocytes (C28) in red.
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We describe here a unique miRNA and mRNA expression dataset
from human chondrosarcoma (JJ012) and chondrocytes (C28)
cell lines. This dataset comprises only array data from ExiqonFig. 5.Volcano plot showing signiﬁcantly (fold change N 1.5 and P-values b 0.05) differentially e
chondrocytes (C28).miRNA array and Illumina mRNA array. The expression data
submitted here is of highest quality and has been used in studies
published recently [3] in journals withwide subscription and impact,
therefore would beneﬁt wider biomedical research through further
sharing.xpressed genes in red after an unsupervised T-test on human chondrosarcoma (SARC) and
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